Algorae Pharmaceuticals Limited (LVCLF) Investment Research Dashboard
About Algorae Pharmaceuticals Limited (LVCLF) stock analysis
Get live LVCLF stock price $0.00, comprehensive Algorae Pharmaceuticals Limited stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time LVCLF stock data and investment insights.
Loading chart data...
Algorae Pharmaceuticals Limited (LVCLF) Overview
Algorae Pharmaceuticals Limited (LVCLF) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, LVCLF trades at $0.00 with a market capitalization of 7.10M . Over the past 52 weeks, LVCLF has traded between $0.00 and $0.01 , with the current price positioned at approximately 0% of this range . The stock currently...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 7.10M
- Current price: $0.00
- 52-week range: $0.00 - $0.01
- P/E ratio: 16.67
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Algorae Pharmaceuticals Limited, established in 1987 and based in Melbourne, Australia, is a pharmaceutical development company. The firm primarily conducts its research and development in New Zealand, focusing on living cell technologies. Its produc...
Company Information
- CEO
- David Richard Hainsworth
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 48
Contact Information
- Website
- http://www.algoraepharma.com
- Address
- Tower 2
- Country
- AU
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 16.7)
✓ Lower volatility stock (Beta: -0.06) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Algorae Pharmaceuticals Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Algorae Pharmaceuticals Limited
- ⚠Investors should consider how Algorae Pharmaceuticals Limited fits within their overall portfolio allocation
Market Cap
7.10M
P/E Ratio (TTM)
16.67
Beta
-0.06
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare LVCLF with peer companies:
- Price
- $7.00+0.00% (1D)
- Market cap
- 19.47M
- Price
- $0.04-27.79% (1D)
- Market cap
- 7.81M
- Price
- $1.15+0.00% (1D)
- Market cap
- 14.40M
- Price
- $0.23-1.26% (1D)
- Market cap
- 29.72M
- Price
- $0.05-3.85% (1D)
- Market cap
- 5.46M
- Price
- $0.01+1.00% (1D)
- Market cap
- 954.86K
- Price
- $0.00+0.00% (1D)
- Market cap
- 5.33M
- Price
- $1.21-8.33% (1D)
- Market cap
- 1.06M
- Price
- $0.01+0.00% (1D)
- Market cap
- 1.63M
- Price
- $0.00+0.00% (1D)
- Market cap
- 9.87K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.